James Dolan's recent sale of Madison Square Garden Sports shares is the largest insider sale in the past year. The sale's timing and the lack of insider buying over the year, coupled with a history of sales, signal caution for potential investors.
Despite Madison Square Garden Sports' high P/S ratio and slow revenue growth, the market anticipates a turnaround. However, with a lower-than-industry growth forecast, the high P/S ratio may not be sustainable, urging investor caution.
The lawsuit against Dolan could potentially impact the reputation and stock performance of Madison Square Garden Entertainment, Sphere Entertainment, and Madison Square Garden Sports. Dolan's attorney has dismissed the lawsuit as having 'absolutely no merit' and being an 'act of retaliation'.
Jonathan Boyar states that the stock is underpriced owing to the 'Dolan discount'. He suggests measures like selling a minority stake in Knicks or Rangers, triggering a stock buyback or a regular dividend distribution could boost stock value. A total company sale might bring the best payoff.
Barrons sees possible 2024 value in these stocks: Alibaba's cheap trading price with a tenfold revenue increase; Alphabet's expected earnings growth; Berkshire's potential earnings spike; BioNTech's oncology focus; Chevron's low-risk growth and yield; Hertz's value for patient investors; potential returns from Madison Square Garden Sports; PepsiCo's dividends and anticipated earnings; U-Haul's self-storage business.
Madison Square Garden Sports Corp.'s shift to profitability amid share price declines and a total shareholder return (TSR) of -6.3% suggests future possibilities. Yet, reducing revenues and absence of dividends could affect these prospects.
The Sphere arena's uncertain financial viability, along with the drop in MSG Networks profits and the abrupt CFO resignation, could have factored into stock price dip.
Gapping up In reaction to earnings/guidance: •$Aehr Test Systems(AEHR.US)$+11.1% (also releases two new enhancements for its FOX-P family of wafer level test and burn-in systems) •$Tilray Brands(TLRY.US)$+5.1% Other news: •$Payoneer Global(PAYO.US)$+8.1% (to join SaP SmallCap 600) •$Atlas(ATCO.US)$+6.8% (continues negotiations with Poseidon Acquisition; parties have made meaningful progress on potential transactio...
麥迪森運動股票討論區
Sports!!! 🏀 ⚽️🏈⚾️🏓🎳🏒🥊🏂
📊⚡️📊
2023前3季度營收增長17.7%,營業利潤增長56.1%到0.97億,淨利潤增長1.5倍達到0.55億。
5年來資產負債率從30%增長到111.2%,2023Q3增長到124.4%,負債率過高。
目前市盈率91.6,市盈率TTM已經下降到56.7,如果全年淨利0.74億,對應市盈率爲62.1,考慮利潤暴增的持續性,再多觀察幾個季度。
專欄Today's Pre-Market Stock Movers: AMD, NVDA, INTC, TSM and More
In reaction to earnings/guidance:
• $Aehr Test Systems(AEHR.US)$ +11.1% (also releases two new enhancements for its FOX-P family of wafer level test and burn-in systems)
• $Tilray Brands(TLRY.US)$ +5.1%
Other news:
• $Payoneer Global(PAYO.US)$ +8.1% (to join SaP SmallCap 600)
• $Atlas(ATCO.US)$ +6.8% (continues negotiations with Poseidon Acquisition; parties have made meaningful progress on potential transactio...
暫無評論